Literature DB >> 32445805

Current incidence of adjacent segment pathology following lumbar fusion versus motion-preserving procedures: a systematic review and meta-analysis of recent projections.

Chester J Donnally1, Parthik D Patel2, Jose A Canseco2, Srikanth N Divi2, Vadim Goz2, Matthew B Sherman2, Kartik Shenoy2, Michael Markowitz2, Jeffery A Rihn2, Alexander R Vaccaro2.   

Abstract

BACKGROUND CONTEXT: Lumbar fusion has shown to be an effective surgical management option when indicated, improving patient outcomes and functional status. However, concerns of adjacent segment pathology (ASP) due to reduced mobility at the operated segment have fostered the emergence of motion-preserving procedures (MPP).
PURPOSE: To assess rates of radiographic adjacent segment degeneration (ASDeg) and symptomatic adjacent segment disease (ASDis) as well as reoperation rates due to ASP in patients who have undergone lumbar fusion compared to motion-preservation for degenerative disorders. STUDY
DESIGN: Systematic Review and Meta-Analysis.
METHODS: Following PRISMA guidelines, a systematic review and meta-analysis was conducted to find current (1/2012-12/2019) retrospective cohort studies and randomized controlled trials evaluating rates of ASDeg, ASDis, and reoperations due to lumbar ASP.
RESULTS: A total of 1,751 patients (791 underwent fusion surgery and 960 motion-preserving procedures) in 19 publications were included in the final analysis. Overall incidence rates of ASDeg, ASDis, and reoperation rates were 27.8%, 7.6%, and 4.6%, respectively. Results showed no significant difference between the lumbar fusion versus MPP cohorts in incidence of ASDeg (36.4% vs. 19.2%, p: 0.06), ASDis (10.7% vs. 4.42%, p: 0.25), or reoperation due to ASP (7.40% vs. 1.80%, p: 0.19). Fixed-effects analysis revealed patients who underwent MPP had significantly lower odds of ASDeg (OR: 2.57, CI: 1.95, 3.35, p<.05) and reoperations (OR: 3.18, CI: 1.63, 6.21, p<.05) compared to lumbar fusion patients.
CONCLUSIONS: This meta-analysis revealed no statistically significant difference in incidence of ASDeg, ASDis, or reoperations due to ASP for patients after lumbar fusion versus MPP. Weighted analysis, however, showed that MPP patients had significantly lower odds of ASDeg and reoperations due to ASP. While previous studies have established the biomechanical efficacy of MPP on cadaveric models, further high-quality studies are required to evaluate the long-term consequences of these procedures on patient-reported outcomes, postoperative complications, and associated inpatient/outpatient costs.
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Keywords:  ASD; Adjacent segment pathology; Dynamic stabilization; Lumbar fusion

Mesh:

Year:  2020        PMID: 32445805     DOI: 10.1016/j.spinee.2020.05.100

Source DB:  PubMed          Journal:  Spine J        ISSN: 1529-9430            Impact factor:   4.166


  5 in total

1.  CORR Insights®: A Dynamic Interbody Cage Improves Bone Formation in Anterior Cervical Surgery: A Porcine Biomechanical Study.

Authors:  Yun Peng
Journal:  Clin Orthop Relat Res       Date:  2021-11-01       Impact factor: 4.755

2.  Adjacent segment pathology of the cervical spine: A case report.

Authors:  Eric C P Chu; Linda Y K Lee
Journal:  J Family Med Prim Care       Date:  2022-02-16

3.  Impact of heterotopic ossification following lumbar total disk replacement: a systematic review.

Authors:  Colleen Hood; Reza Zamani; Mohammad Akrami
Journal:  BMC Musculoskelet Disord       Date:  2022-04-23       Impact factor: 2.562

4.  Proximal junctional kyphosis is a compensation for post-operative negative C2-FH in ASD patients: a cross-sectional study.

Authors:  Xin Zhang; Shibin Shu; Zezhang Zhu; Qi Gu; Zhen Liu; Yong Qiu; Hongda Bao
Journal:  J Orthop Surg Res       Date:  2022-10-07       Impact factor: 2.677

5.  A Minimally Invasive Technique Using Cortical Bone Trajectory Screws Assisted by 3D-Printed Navigation Templates in Lumbar Adjacent Segment Degeneration.

Authors:  Kun He; Chunke Dong; Hongyu Wei; Feng Yang; Haoning Ma; Xiangsheng Tang; Mingsheng Tan; Ping Yi
Journal:  Clin Interv Aging       Date:  2021-07-20       Impact factor: 4.458

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.